1.Hypertensive effect of sublingual captopril
Journal of Vietnamese Medicine 1999;232(1):11-14
32 patients (male: 21) with average ages of 62 (11,4, hypertension (systolic blood pressure: 180mmHg, diastolic blood pressure: 110 mmHg) received the sublingual captopril at dose of 25 mg. The hemodynamometery was implemented before and after 5, 15, 30 and 60 minutes of using the drug. If the blood pressure was not reduced to wanted level, the patient indicated more one tablet. If the blood pressure did not reduce about 25%, patients will be treated by combination of captopril with other drugs. The results have shown that efficacy at dose of 25 mg, 15 cases, at dose of 50 mg: 12 cases; ineffect and poor effect: 5 cases. Initial time of effect: 7 (1.04 minutes after using; time for maximum effect: 61 (24.3 minutes after using. The study concluded that captopril can be used in the urgent hypertension
Hypertension
;
Captopril
2.A case of type 4 renal tubular acidosis resulting from captopril administration.
Jeong Eun PARK ; Gyu Bog CHOI ; Kyun Il YOON
Korean Journal of Nephrology 1991;10(4):620-624
No abstract available.
Acidosis, Renal Tubular*
;
Captopril*
3.Captopril in Children with Renovacular Hypertension.
Yong CHOI ; Hoan Jong LEE ; Hee Young SHIN ; Kwang Wook KO ; Chang Yee HONG
Journal of the Korean Pediatric Society 1985;28(1):58-67
No abstract available.
Captopril*
;
Child*
;
Humans
;
Hypertension*
4.A preparation of captopril sustained release tablet
Journal of Medical and Pharmaceutical Information 2004;0(8):28-31
to build formula of captopril sustained release matrix tablets with EC and HPMC, survey the affects of formulation components and optimization of formula by using D- Optimal. Subject: captopril, EC, HPMC, lactose, and starch. Method: prepare tablet, assess the quality of captopril sustained release matrix tablets. Conclusions: From the experiment design, captopril sustained release oral tablets with half life of 12h can be prepared, and by optimized method, the proper formula was found. To produce captopril tablets, it's necessary to further study in large scale, to perform test of bio-equivalence and stability of tablet
Captopril
;
Tablets
;
Pharmaceutical Preparations
5.Findings and clinical significance of captopril 99mTc-DTPA renal scintigraphy in renovascular hypertension.
Dong Wan CHAE ; Curie AHN ; Jin Suk HAN ; Suhnggwon KIM ; Jung Sang LEE
Korean Journal of Nephrology 1991;10(4):545-554
No abstract available.
Captopril*
;
Hypertension, Renovascular*
;
Radionuclide Imaging*
6.Acantholysis Induction in Skin Explant Cultures Using Drugs ( d - penicillamine , rifampicin and captopril ).
Korean Journal of Dermatology 1990;28(5):509-518
No abstract available.
Acantholysis*
;
Captopril*
;
Penicillamine*
;
Rifampin*
;
Skin*
7.Effects of nifedipine and captopril on cisplatin induced nephrotoxity in rats.
Byung Hee YU ; Jong Sik HAH ; Ku Ja KIM ; Nan Ho KYUNG
Korean Journal of Nephrology 1991;10(3):360-371
No abstract available.
Animals
;
Captopril*
;
Cisplatin*
;
Nifedipine*
;
Rats*
8.The long-term effect of captopril on steroid resistent nephrotic syndrome in children.
Jo Won JUNG ; Kyung Chong YU ; Ki Soo PAE ; Jae Seung LEE
Korean Journal of Nephrology 1991;10(2):150-156
No abstract available.
Captopril*
;
Child*
;
Humans
;
Nephrotic Syndrome*
9.The long-term effect of captopril on steroid resistent nephrotic syndrome in children.
Jo Won JUNG ; Kyung Chong YU ; Ki Soo PAE ; Jae Seung LEE
Korean Journal of Nephrology 1991;10(2):150-156
No abstract available.
Captopril*
;
Child*
;
Humans
;
Nephrotic Syndrome*
10.Captopril 99mTc-DTPA renal scintigraphy in diagnosis of renovascular hypertension.
Hyung In YANG ; Dong Soo LEE ; Sung Chul KIM ; Sang Kyun BAE ; Chang Woon CHOI ; June Key CHUNG ; Suhnggwon KIM ; Myung Chul LEE ; Jung Sang LEE ; Chang Soon KOH
Korean Journal of Nuclear Medicine 1992;26(2):312-317
No abstract available.
Captopril*
;
Diagnosis*
;
Hypertension, Renovascular*
;
Radionuclide Imaging*
Result Analysis
Print
Save
E-mail